AstraZeneca CEO Wants to Move Listing to US, Times Reports
Published on July 3, 2025
AstraZeneca Plc’s Chief Executive Officer Pascal Soriot wants to move the drugmaker’s stock listing to the US, the Times reported, in what would be another sign of the UK’s waning status as a magnet for global capital.